Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema

BACKGROUND: Asymmetric dimethylarginine (ADMA)––the most potent endogenous NO-synthase inhibitor, has been regarded as mediator of endothelial dysfunction and oxidative stress. Considering experimental data, levels of ADMA and its structural isomer symmetric dimethylarginine (SDMA) might be elevated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neuroinflammation
Main Authors: Worthmann, Hans, Li, Na, Martens-Lobenhoffer, Jens, Dirks, Meike, Schuppner, Ramona, Lichtinghagen, Ralf, Kielstein, Jan T., Raab, Peter, Lanfermann, Heinrich, Bode-Böger, Stefanie M., Weissenborn, Karin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729507/
https://ncbi.nlm.nih.gov/pubmed/29237474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-1016-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados